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During six months of annual hibernation, the brown bear undergoes unique physiological changes 
to adapt to decreased metabolic rate. We compared cardiac structural and functional measures of 
hibernating and active bears using comprehensive echocardiography. We performed echocardiography 
on 13 subadult free-ranging, anaesthetised Scandinavian brown bears (Ursus arctos) during late 
hibernation and in early summer. Mean heart rate was 26 beats per minute (standard deviation (SD): 8)  
during hibernation vs 71 (SD: 14) during active state. All left ventricular (LV) systolic and diastolic 
measures were decreased during hibernation: mean ejection fraction: 44.2% (SD: 6.0) active state 
vs 34.0 (SD: 8.1) hibernation, P = 0.001; global longitudinal strain: −11.2% (SD: 2.0) vs −8.8 (SD: 
3.3), P = 0.03; global longitudinal strain rate: −0.82 (SD: 0.15) vs −0.41 (SD: 0.18), P < 0.001; septal 
e’: 9.8 cm/s (SD: 1.8) vs 5.2 (SD: 2.7), P < 0.001. In general, measures of total myocardial motion 
(ejection fraction and global longitudinal strain) were decreased to a lesser extent than measures of 
myocardial velocities. in the hibernating brown bear, cardiac adaptation included decreased functional 
measures, primarily measures of myocardial velocities, but was not associated with cardiac atrophy. 
Understanding the mechanisms of these adaptations could provide pathophysiological insight of 
human pathological conditions such as heart failure.
To cope with the harsh environment during winter, the Scandinavian brown bear (Ursus arctos) has developed 
remarkable physiological adaptations. Each fall with a shortage of food and decreasing ambient temperature, the 
bear enters a 5–7 months hibernation period. During this time, the bear does not eat, drink, defecate or urinate 
and is only minimally physical active1. In addition, and contrary to most other hibernators, the Scandinavian 
brown bear is a shallow hibernator with a certain amount of alertness during the entire hibernation period and 
only a slight decrease in body temperature to approximately 33–34 °C2. Despite this extreme exposure the bear 
stays apparently free from any pathophysiological states associated with prolonged physical inactivity and avoids 
loss of muscle and bone mass3–5.
To conserve energy, the bear’s oxygen demand is reduced to approximately 25% of the active state6 and to opti-
mise energy consumption the cardiovascular system adapts accordingly. Previous studies in American brown and 
black bears (Ursus americanus) have suggested that cardiac adaptations during hibernation are characterized by 
a marked decrease in cardiac output caused by profound bradycardia with extreme respiratory sinus arrhythmia 
and a preserved left ventricular (LV) ejection fraction. Hibernation is also characterized by a decrease in LV mass/
volume ratio indicating some degree of cardiac remodelling to adapt to the altered hemodynamic state7–9. We 
have previously documented low flow hemodynamics in the hibernating Scandinavian brown bear by reporting 
reduced cardiac output and presence of spontaneous echo contrast10.
On the contrary, even a short period of immobility in humans can lead to a number of adverse effects includ-
ing a reduction in muscle and bone mass, decubitus ulcers and thromboembolic events11. Cardiac implications 
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of immobility documented in bed-rest studies12 and studies of astronauts returning from space13 have suggested 
cardiac atrophy to occur in response to immobility.
Over the past decade, several of echocardiographic modalities such as tissue Doppler imaging and 2D speckle 
tracking have been developed allowing detection of subtle changes in myocardial function. These methods allow 
assessment of LV myocardial tissue velocities and tissue deformation with high accuracy and have not been 
employed in a hibernating bear model previously. Additionally, previous studies examining cardiac structure and 
function have been conducted in hibernating bears that were hand-raised or in bears that were only examined 
during the hibernation period. Thus, we aimed to perform a comprehensive cardiac structural and functional 
evaluation in hibernating vs active free-ranging Scandinavian brown bears using tissue Doppler and 2D speckle 
tracking echocardiography and interpret the findings in a human context. Evidently, identification of the factors 
responsible for tissue preservation during hibernation has potential to impact human medicine in a variety of 
fields including cardiogenic shock, thromboembolism and space medicine.
Methods
Materials. We performed comprehensive echocardiography, including tissue Doppler imaging and 2D 
speckle tracking in free-ranging, subadult Scandinavian brown bears during the hibernating and active state 
in Dalarna, Sweden. All bears were marked with GPS collars and VHF transmitters as part of the Scandinavian 
Brown Bear Research Project (https://bearproject.info/) which allowed us to locate the bears in their dens during 
hibernation and in their habitat during the active state. Bears were immobilised in late February and again in 
June/early July from 2014 to 2018. During the winter captures, bears were located in their dens and anaesthetised 
with a mixture of medetomidine, zolazepam, tiletamine and ketamine. During summer captures, the same bears 
were darted from a helicopter with a mixture of medetomidine, zolazepam and tiletamine at 2–4 times the winter 
dose to account for the metabolic rate during active state14. Both winter and summer, ketamine could be admin-
istered if the effect of anaesthesia was decreasing. Doses administered and weight of each of the bears is shown in 
Supplemental Table 1. The study was approved by the Swedish Ethical Committee on Animal Research (C268/12 
and C3/16), and the procedures were performed in compliance with Swedish laws and regulations.
echocardiography. We performed echocardiography in the field on bears in a left lateral recumbency posi-
tion. We used a General Electrics Vivid i (GE healthcare, Horton, Norway) with 5S-RS and 3S-RS probes to obtain 
2D images, M-mode, pulsed, continuous wave and tissue Doppler echocardiography. We used GE EchoPAC 
software (EchoPAC 113.1.5.6, GE Vingmed Ultrasound AS, Strandpromenaden 45, 3191 Horten, Norway) to 
perform post-processing of the echocardiograms. Three apical views (4-chamber, 2-chamber and apical long-axis 
view) were recorded and, where possible, a parasternal long-axis view was also obtained. Following the European 
Association of Cardiovascular Imaging guidelines, LV mass was approximated with the Cube formula that has 
been validated in humans (LV mass = 0.8 × {1.04[(LV internal diameter + posterior wall thickness + septal wall 
thickness)3 − (LV internal diameter)3]} + 0.6 g)15. LV dimensions were measured in end-diastole in the paraster-
nal long-axis view and indexed according to estimated body surface16 to account for differences related to the 
growth of the subadult animals. 2D-speckle tracking strain and strain rate were measured in the apical 4-, 2- 
and long axis view in a total of 18 segments. The region of interest was traced by a semi-automated process and 
adjusted manually to cover the entire LV wall after visual inspection. Segments that were not traced by the soft-
ware were excluded from the analyses. The mean values of mid-ventricular global longitudinal strain and strain 
rate from the three projections reported by the software were used in this study. An example is shown in Fig. 1C. 
Mitral valve inflow velocities, early (E) and atrial (A) velocities and deceleration time were measured with the 
sample volume placed between the tips of the mitral valve leaflets. Peak early (e’), atrial (a’) and systolic (s’) myo-
cardial velocities were measured with pulsed-wave tissue Doppler with the sample volume placed in the septal 
and lateral mitral annulus as demonstrated in Fig. 1A,B. Isovolumetric relaxation time was calculated from these 
curves as the time between end of systolic to onset of early diastolic myocardial velocity wave and reported as the 
mean of the septal and lateral values. Left atrial end volumes and emptying/ejection fraction were calculated using 
Simpson’s biplane method from apical 2- and 4-chamber views15. Right ventricular fractional area change was 
calculated as (end-diastolic area – end-systolic area)/end-diastolic area, measured in a modified apical 4-chamber 
view with a focus on the right ventricle. Tricuspid annular plane systolic excursion (TAPSE) was also obtained in 
this view with use of M-mode. All measurements were obtained in all bears except right ventricular area meas-
urements that were not analyzable in one bear. Heart rate was the mean of 3 measurements performed during the 
2D speckle tracking analyses. An experienced echocardiographer (PGJ) performed all echocardiographies and 
post-processing.
Statistics. The values are presented as mean ± standard deviation (SD), and differences between hibernating 
and active state were compared using a paired t-test. P-values less than 0.05 were considered statistically signif-
icant. The calculations were made using the statistical software package ‘R’, version 3.4.3 (64 bit) (R Project for 
Statistical Computing, http://www.R-project.org).
Results
A total of 13 bears, 4 males and 9 females, were studied during the hibernating and active state. Two of the bears 
were studied two consecutive years and included in the analyses separately. All bears were subadults, three were 3 
years old, and nine were 2 years old. Mean weight was 45.6 kg (SD: 9.3) in the active state versus 40.5 kg (SD: 10.9) 
during hibernation (p = 0.02). Heart rate was considerably lower during hibernation, 26 beats per minute (SD: 8) 
vs 71 (SD: 14) during active state (p < 0.001).
The echocardiographic measurements are presented in Table 1. None of the structural measurements were 
significantly changed during hibernating compared to an active state. Thus, neither LV mass, myocardial wall 
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thicknesses nor volumes were altered (p > 0.05 for all). In contrary, the majority of the functional measurements 
were reduced during hibernation. Regarding systolic measurements, LV ejection fraction, global longitudinal 
strain and strain rate and peak systolic velocities were reduced during hibernation, Fig. 2. This pattern was, how-
ever, more pronounced regarding the myocardial velocity measurements. While the measures of total cardiac 
motion were only modestly affected with a 23% relative reduction in LV ejection fraction and 21% reduction in 
global longitudinal strain, the measures of myocardial velocities were reduced to a larger extent - global longitu-
dinal strain rate by 50% and septal and laterals’ by 39% and 45%, respectively. In contrast to the LV measures, 
neither left atrial structure nor function (except lateral a’) were significantly altered during the active state. LV 
diastolic measurements, Table 1 and Fig. 3, were all significantly lower during hibernation compared to active 
state except mitral valve inflow deceleration time, E/A ratio and lateral e’/a’. The E/e’ seemed to be highly affected 
by one observation, Fig. 3. By excluding this bear, the increase in E/e’ during hibernation is still significant, 
P = 0.02. This pattern of preserved structure and reduced function was also found in right ventricular meas-
urements, where unaltered systolic and diastolic areas were accompanied by significantly decreased functional 
measures expressed as tricuspid annular plane systolic excursion (TAPSE) and fractional area change, Fig. 4.
Discussion
We have examined cardiac adaptations to the annual hibernation in free-ranging Scandinavian brown bears using 
contemporary, comprehensive echocardiography. While there was no evidence of structural adaptation such as 
atrophy during hibernation, we found that both left and right ventricular systolic and LV diastolic function were 
reduced during hibernation. Interestingly, using advanced measures of cardiac deformation and tissue veloci-
ties, we found that the relative decrease in function was largest for velocity measures such as global longitudinal 
strain rate, s’ and e’, compared to the volumetric and maximum deformation measures. This indicates that cardiac 
adaptation affects tissue velocities more than the actual magnitude of contraction. Of note, we did not find any 
difference in atrial size nor function (except lateral a’, which was lower during hibernation) and only a borderline 
change in early and late diastolic relative contribution to LV filling expressed as E/A ratio, e’/a’.
To the best of our knowledge this study is the first to demonstrate considerably reduced LV myocardial veloc-
ities using new, sensitive measures, of myocardial function, i. e. tissue Doppler imaging and 2D speckle tracking 
imaging in hibernating bears. In humans, heart failure – defined as a chronic condition in which the heart’s ability 
to pump blood is unable to meet the tissue’s oxygen demands at normal filling pressures – is also characterised by 
decreased myocardial velocities that have consistently shown to be associated with poor prognosis17–21. Though 
the bear shares similarities to patients with heart failure, including reduced ejection fraction and myocardial 
velocities, these are not associated with any pathophysiological symptoms or prognosis in hibernating bears. In 
Figure 1. Examples of pulsed wave tissue Doppler echocardiographic and 2D-speckle tracking measurements. 
S’, e’ and a’ during hibernation (A) and active state (B) and of 2D-speckle tracking strain measurements with 
an arrow pointing at peak systolic strain (C). Images were exported from EchoPAC 113.1.5.6, GE Vingmed 
Ultrasound AS, Strandpromenaden 45, 3191 Horten, Norway. URL: https://www.gehealthcare.com/.
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heart failure, decreased left and right ventricular function is associated with cardiac remodelling as a compen-
satory mechanism. In the early stages, heart failure with preserved ejection fraction is associated with increased 
filling pressures leading to pressure increase in and dilation of the left atrium. At a later stage in heart failure 
with reduced ejection fraction, to compensate for decreased stroke volume, LV remodelling including increas-
ing volumes and wall thickness ensure to maintain adequate stroke volume and cardiac output22. According to 
our results, the bear’s heart does not remodel as a compensatory mechanism to decreased myocardial function 
indicating perfect adaptation during hibernating. We believe that the reduced function is not accompanied by an 
increase in filling pressures because the cardiovascular system during hibernation is a low flow system as we have 
previously described10.
The fact that the bear is able to modulate contractile forces during hibernation underlines the prospects of the 
hibernating bear heart as a useful model of understanding heart diseases in humans. Revealing the mechanisms 
of these modulations could have potentially considerable benefits in human medicine. In our study, the myocar-
dial velocities were more decreased compared to volumetric and deformational measures. In the cardiac myocyte, 
the force generated is dependent on intracellular Ca2+ released from the sarcoplasmic reticulum during contrac-
tion and sensitivity of myosin filaments to Ca2+ 23. Also, previous studies have suggested that body temperatures 
below 30 °C are required to effectively alter Ca2+ dynamics24,25 and, therefore, temperature alone is unlikely to be 
responsible for the cardiac adaptations found as the hibernating brown bear keeps a temperature at approximately 
33 °C during hibernation2. As a consequence, our study indicates, that handling of Ca2+ and the sensitivity to 
Ca2+ in contractile proteins are potentially involved in the myocardial adaptations in the hibernating brown bear.
Our finding of a preserved cardiac structure is in accordance with previous studies on cardiac structure in 
hibernating bears. In 2003 and 2008 Nelson et al. conducted research on captive, hibernating brown bears. In 
Active state Mean (sd) Hibernating state Mean (sd) p-value
Left ventricular structure
Left ventricular mass index (g/m2) 171 (24) 151 (28) 0.07
Septum thickness index (cm/m2) 0.91 (0.16) 0.83 (0.12) 0.19
Diastolic internal diameter (cm/m2) 4.1 (0.4) 4.5 (0.7) 0.14
Posterior wall thickness (cm/m2) 0.81 (0.13) 0.77 (0.11) 0.40
Left ventricular end diastolic volume (ml/m2) 105 (18) 94 (4) 0.12
Left ventricular end systolic volume (ml/m2) 58 (12) 62 (12) 0.43
Left ventricular systolic function
Left ventricular ejection fraction (%) 44.2 (6.0) 34.0 (8.1) 0.001
Global longitudinal strain (%) −11.2 (2.0) −8.8 (3.3) 0.032
Global longitudinal strain rate (s−1) −0.82 (0.15) −0.41 (0.18) <0.001
Septal s’ (cm/s) 7.5 (1.1) 4.6 (1.9) <0.001
Lateral s’ (cm/s) 9.3 (2.6) 5.1(2.4) <0.001
Left ventricular diastolic function
Isovolumetric relaxation time (ms) 102 (18) 199 (68) <0.001
Mitral valve inflow deceleration time (ms) 96 (31) 123 (76) 0.23
A velocity (m/s) 0.48 (0.17) 0.33 (0.08) 0.009
E velocity (m/s) 0.69 (0.20) 0.45 (0.16) 0.003
E/A ratio 1.6 (0.6) 1.4 (0.6) 0.58
Lateral e’ (cm/s) 12.4 (4.6) 6.0 (4.6) 0.002
septal e’ (cm/s) 9.8 (1.8) 5.2 (2.7) <0.001
e’/a’ lateral 2.0 (0.9) 1.2 (0.9) 0.053
e’/a’ septal 1.3 (0.4) 0.9 (0.6) 0.046
E/e' 6.0 (1.6) 10.8 (7.2) 0.028
Left atrial structure and function
Left atrial end systolic volume index (ml/m2) 25 (10) 23 (5) 0.41
Left atrial end diastolic volume index (ml/m2) 41 (11) 37 (7) 0.34
Left atrial emptying fraction (%) 38 (18) 38 (14) 0.90
Septal a’ (cm/s) 7.7 (1.3) 7.3 (2.6) 0.61
Lateral a’ (cm/s) 6.7 (1.8) 4.9 (1.5) 0.010
Right ventricular function
TAPSE (cm) 1.9 (0.3) 1.4 (0.4) 0.002
*Systolic area (cm2) 8.3 (2.3) 8.5 (1.8) 0.81
*Diastolic area (cm2) 12.5 (3.1) 10.7 (2.3) 0.13
*Fractional area change (%) 34.3 (7.3) 20.5 (9.1) <0.001
• Indicates measures only available in 12 bears.
Table 1. Echocardiographic findings in active vs hibernating Scandinavian Brown Bear.
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the first study, they found no difference in septal thickness8, whereas in the second, bears showed reduced septal 
thickness26. Both studies, however, reported unaltered LV end-diastolic diameters during hibernation. Laske et al. 
studied the structural changes in black bears from early through late hibernation period and found no differences 
in LV wall thicknesses7.
In our study, all systolic measures were reduced during hibernation, including measures of myocardial veloc-
ities such as global longitudinal strain, strain rate and s’ that were relatively more reduced than measures of 
total cardiac motion such as LV ejection fraction and global longitudinal strain. Our results contrast findings of 
Nelson et al., who initially also reported a decreased LV ejection fraction in anaesthetised captive brown bears8, 
but later reported preserved ejection fraction in unanaesthetised captive brown bears9. An apparent reason for 
this discrepancy could be the use of anaesthesia in our bears. In Nelson’s study of anesthetised bears, a cocktail of 
tiletamine and zolazepam was administered to induce and isoflurane was used to sustain anesthesia during the 
Figure 2. Systolic functional measures in active vs hibernating Scandinavian Brown Bear.
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examination. The isolated effect of isoflurane on the bear heart is unknown, but in rabbits isoflurane lowers blood 
pressure and cardiac function27. In humans, on the other hand, isoflurane only has limited effect on cardiac func-
tion28, though this might be age dependent29. Thus, the reduced ejection fraction in anesthetised bears in Nelson’s 
early study might be caused by the use of isoflurane but this remains speculative. Another reason for the discrep-
ancy could also be due to differences in image acquisition and calculations of LV ejection fraction. In our study, 
we used Simpson’s biplane method which is the currently recommended method in clinical practice in humans15 
and Nelson et al. used area length method from the parasternal long axis view (Nelson, personal communication). 
The atrial function was unaltered during hibernation in our study. This result is in discrepancy with the findings 
of Nelson et al. who described decreased atrial function – by both 2D and strain echocardiography - during 
hibernation and ascribed this as a consequence/adaptation to increased LV stiffness interpreted as increased 
Figure 3. Diastolic functional measures in active vs hibernating Scandinavian Brown Bear.
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isovolumetric relaxation time9,30. Isovolumetric relaxation time was also dramatically increased during hiber-
nation in our study. However, based partly on our findings of altered myocardial velocities, we believe that this 
is mainly caused by other factors than increased myocardial stiffness: isovolumetric relaxation time is a marker 
of decreased diastolic function and is affected in a number of diseases, but is also dependent of end-systolic left 
atrial pressure and shortens with increasing left atrial pressure and vice versa31. Beyond this, LV relaxation rate is 
determined by reuptake of Ca2+ in the sarcoplasmic reticulum of the myocyte. This process occurs through the 
action of sarco(endo)plasmic reticulum Ca2+ ATPase which is highly sensitive to adrenergic stimuli32. Thus, with 
respect to our previous finding of low cardiac output in hibernating brown bears, we believe that the prolonged 
isovolumetric relaxation time is caused by low end-systolic left atrial pressure as well as a presumed minimal 
adrenergic state in bears during hibernation.
We have demonstrated profound changes in cardiac function during hibernation in Scandinavian brown 
bears. The characteristics of myocardial metabolism during the hibernating state is unknown. Free fatty acid 
oxidation is responsible for approximately 70% of myocardial energy expenditure in the healthy human heart and 
up to a 70% decrease in free fatty acid oxidation has been observed in the failing heart accompanied by decreased 
substrate flexibility33,34. In the search for innovative treatments targeting fatty acid metabolism in heart failure, 
knowledge of adaptations in metabolism during hibernation might prove useful35. Latest could be investigated 
using injected tracers that are examined either directly from blood samples from cardiac catheterization33 or by 
positron emission tomography36. At present, Ca2+ metabolism is already an established target in heart failure 
therapy in humans with the agent levosimendan which is a Ca2+-sensitizer acting through binding to the cardiac 
troponin C molecule – a modulator of force of contraction in the cardiomyocyte37. However, further knowledge 
of the bear’s possible ability to effectively control Ca2+ transfer? is essential for providing insights into the mech-
anisms required to effectively control this process.
A strength of this study is that we studied free-ranging Scandinavian brown bears in their natural habitat, includ-
ing natural denning behaviour and denning physiology. Also, we examined the highest number of hibernating and 
active bears reported to date using echocardiography. A significant limitation is that we used bears anaesthetised 
with agents possibly affecting cardiac functional measures. This may explain the slightly depressed LV function dur-
ing active state although no previous studies have established average values of LV ejection fraction using the gold 
standard Simpson’s biplane method and global longitudinal strain in unanaesthetised active brown bears.
Ketamine was only used on a routine basis during winter captures and since ketamine is believed to have 
centrally mediated sympathomimetic effects38, the use of ketamine would theoretically cause changes opposite to 
those observed in this study. Additionally, during anaesthesia, we used doses that were titrated based on careful 
monitoring according to the depth of anaesthesia during both summer and winter captures. Moreover, we found 
no consistent correlation between dose of the anaesthetic agents and the cardiac measures (data not shown). 
On the other hand, anaesthesia allowed us to examine the bear heart from the apical position by applying firm 
pressure to the thoracic wall and slightly displace the sternum which is unlikely to be possible in wake bears. By 
doing this, we could obtain reliable Doppler measurements (both spectral and tissue Doppler) that are otherwise 
angle sensitive.
Figure 4. Right ventricular functional measures in active vs hibernating Scandinavian Brown Bear.
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conclusion
We used comprehensive echocardiography to characterise cardiac adaptations in hibernating brown bears. While 
we found no evidence of cardiac atrophy during hibernation, we demonstrated a decrease in functional measures. 
The measurements of cardiac velocities changed the most, which may indicate changes to Ca2+ transfer handling 
during hibernation. Identification of factors responsible for the remission of decreased cardiac functional meas-
ures could have implications for the management of human patients with a number of conditions including heart 
failure.
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